Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
01/2011
01/25/2011CA2469594C Crystal of bicalutamide and production method thereof
01/25/2011CA2441834C Lipid profile modulation
01/25/2011CA2434299C Tricyclic androgen receptor modulator compounds and methods
01/20/2011WO2011007865A1 Agent for inhibiting increase in postprandial blood insulin level
01/20/2011WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
01/20/2011WO2011006497A1 Acylated glucagon analogues
01/20/2011WO2010032006A3 Treatment of adrenal insufficiency
01/20/2011US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
01/20/2011US20110015276 Therapeutical uses of inecalcitol
01/20/2011US20110015210 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
01/20/2011US20110015164 Method of treating men with metabolic and anthropometric disorders
01/20/2011US20110015161 Pharmaceutical containing a horomone combination having a contraceptive effecr and an insulin sensitizer
01/20/2011US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK
01/20/2011US20110014251 Microvesicles
01/20/2011US20110014200 Monoclonal antibody that suppresses thyrotropin receptor constitutive activity
01/20/2011US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
01/20/2011US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds
01/20/2011US20110014160 DDR1-Mediated Cell Purification of Pancreatic Endocrine Cells Through Their Progenitors
01/20/2011CA2767792A1 Acylated glucagon analogues
01/20/2011CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
01/19/2011EP2275557A1 Albumin fusion proteins
01/19/2011EP2275439A2 Novel insulin derivatives
01/19/2011EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders
01/19/2011EP2274978A1 Methods for treatment of insulin-like growth factor-I(IGF-I) deficiency
01/19/2011EP2274316A1 Ligands of estrogen receptors and , method of their preparation and pharmaceuticals comprising them
01/19/2011EP1547614B1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
01/19/2011CN101948539A IL-18 binding proteins
01/19/2011CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof
01/19/2011CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same
01/19/2011CN101948416A Compound used for treating metabolic disorder
01/19/2011CN101947310A Adrenocorticotropic hormone analogs and related methods
01/19/2011CN101947306A Treatment of T-cell mediated diseases
01/19/2011CN101947251A Method for preparing chickpea isoflavone microcapsules
01/19/2011CN101947231A Medicament for emasculating sows
01/19/2011CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof
01/18/2011US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma
01/18/2011US7871994 at least one ingestion period preceding the permanent administration of hormone daily units has an ingestion pause in which either no daily units or units with a much lower hormone content is given
01/18/2011US7871644 Mixture of drug, aminoacrylate polymer and acid
01/18/2011CA2568590C Propane-1,3-dione derivative or salt thereof useful as gnrh receptor antagonist
01/18/2011CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
01/18/2011CA2331460C Heterocyclic inhibitors of p38
01/13/2011WO2011005969A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis
01/13/2011US20110010784 Insulin-like gene of prawns and uses thereof
01/13/2011US20110009443 Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors
01/13/2011US20110009428 Novel androgens
01/13/2011US20110009427 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof
01/13/2011US20110009377 Azetidine derivatives, their preparation and their application in therapy
01/13/2011US20110009347 Combination therapy for the treatment of diabetes
01/13/2011US20110009318 Transdermal Compositions and Methods for Treatment of Fibromyalgia and Chronic Fatigue Syndrome
01/13/2011US20110008464 Methods and compositions for treating thyroid-related medical conditions with reduced folates
01/13/2011US20110008423 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders
01/13/2011US20110008395 Mixed micelles including amphipathic conjugates of rna agents, and uses thereof
01/13/2011US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity
01/13/2011US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof
01/13/2011US20110008297 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
01/13/2011CA2767112A1 Etomidate analogues that do not inhibit adrenocortical steroid synthesis
01/13/2011CA2766008A1 Composition for the treatment of benign prostate hyperplasia
01/12/2011EP2272875A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof
01/12/2011EP2272869A2 Angiopoietin-2 specific binding agents
01/12/2011EP2271405A2 Nip thiazole derivatives as inhibitors of 11-beta-hydorxysteroid dehydrogenase-1
01/12/2011EP2271320A1 Raloxifene pharmaceutical formulations
01/12/2011EP1987006B1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
01/12/2011EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY
01/12/2011EP1272206B1 A chicken II GnRH analog for use in reducing tumor cell growth
01/12/2011CN101945853A Selective androgen receptor modulators (sarms) and uses thereof
01/12/2011CN101940550A Preparation method of gonadotropin releasing hormone liposome
01/11/2011US7868193 Contraceptives; hormone replacement therapy
01/11/2011US7867990 Steroid hormone products and methods for preparing them
01/11/2011US7867986 Enhanced drug delivery in transdermal systems
01/11/2011CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative
01/11/2011CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
01/11/2011CA2422054C Bicyclic heteroaromatic compounds
01/11/2011CA2400486C Aniline-derived ligands for the thyroid receptor
01/11/2011CA2387095C Compound with growth hormone releasing properties
01/06/2011WO2011002332A1 Synthetic peptides having anti-stress activity
01/06/2011WO2011002001A1 Combined medicine of pyrazole derivative and biguanide drug
01/06/2011WO2011000210A1 Composition of permeation enhancer and use thereof in transdermal drug delivery system
01/06/2011WO2010130980A3 A fertilized, incubated avian egg or extract for the treatment of stress
01/06/2011WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors
01/06/2011US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses
01/06/2011US20110003824 Caspase Inhibitors and Uses Thereof
01/06/2011US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
01/06/2011US20110003782 23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof
01/06/2011US20110003750 Human 3 relaxin
01/06/2011US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof
01/06/2011US20110003746 Protein variants
01/06/2011US20110002965 Immunomodulating compounds and related compositions and methods
01/05/2011EP2270049A2 Recombinant anti-interleukin-9-antibody
01/05/2011EP2270005A1 Prodrug of an ice inhibitor
01/05/2011EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment
01/05/2011EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
01/05/2011EP2269613A2 Solid orald dosage form comprising a combination of metformin and glibenclamide
01/05/2011CN101935656A Gene for promoting insulin secretion, preparation method and application thereof
01/05/2011CN101935301A Modulators of ATP-binding cassette transporters
01/05/2011CN101934078A Pharmaceutical composition comprising drospirenone and estrogen, and application thereof
01/05/2011CN101934015A Traditional Chinese medicinal composition for treating thyroid and method for preparing dispelling-goitre cataplasm thereof
01/04/2011US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders
01/04/2011US7863047 Intracorporeal medicaments for photodynamic treatment of disease
01/04/2011CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
01/04/2011CA2456901C Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 290